BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38396958)

  • 1. Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.
    Fasler-Kan E; Milošević M; Ruggiero S; Aliu N; Cholewa D; Häcker FM; Dekany G; Bartenstein A; Berger SM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
    Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
    Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
    Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
    Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.
    Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J
    Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piranha-etched titanium nanostructure reduces biofilm formation in vitro.
    Mukaddam K; Astasov-Frauenhoffer M; Fasler-Kan E; Ruggiero S; Alhawasli F; Kisiel M; Meyer E; Köser J; Bornstein MM; Wagner RS; Kühl S
    Clin Oral Investig; 2023 Oct; 27(10):6187-6197. PubMed ID: 37653076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer immune escape: the role of antigen presentation machinery.
    Kallingal A; Olszewski M; Maciejewska N; Brankiewicz W; Baginski M
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):8131-8141. PubMed ID: 37031434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens.
    Hu Q; Bian Q; Rong D; Wang L; Song J; Huang HS; Zeng J; Mei J; Wang PY
    Front Bioeng Biotechnol; 2023; 11():1110765. PubMed ID: 36911202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.
    Royer-Pokora B; Wruck W; Adjaye J; Beier M
    PLoS One; 2023; 18(1):e0270380. PubMed ID: 36689432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins.
    Schlichtner S; Yasinska IM; Lall GS; Berger SM; Ruggiero S; Cholewa D; Aliu N; Gibbs BF; Fasler-Kan E; Sumbayev VV
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36599470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death by TNF: a road to inflammation.
    van Loo G; Bertrand MJM
    Nat Rev Immunol; 2023 May; 23(5):289-303. PubMed ID: 36380021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JAK-STAT pathway at 30: Much learned, much more to do.
    Philips RL; Wang Y; Cheon H; Kanno Y; Gadina M; Sartorelli V; Horvath CM; Darnell JE; Stark GR; O'Shea JJ
    Cell; 2022 Oct; 185(21):3857-3876. PubMed ID: 36240739
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.